ArticleJournal of hematology & oncology2025

The genomic and epigenomic abnormalities of plasma cfDNA as liquid biopsy biomarkers to detect hepatocellular carcinoma: a multicenter cohort study.

Dezhen Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.